Cytoplasmic polyadenylation element binding protein is a conserved target of tumor suppressor HRPT2/CDC73

Cell Death and Differentiation

Volumn 17, Issue 10, 2010, Pages 1551-1565

  Zhang, J H ^a   Panicker, L M ^a   Seigneur, E M ^a   Lin, L ^a,c   House, C D ^a,d   Morgan, W ^a,e   Chen, W C ^a   Mehta, H ^a   Haj Ali, M ^a   Yu, Z X ^b   Simonds, W F ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^c GEORGETOWN UNIVERSITY   (United States)

^d GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Akt1S1; longevity; Paf1 complex; parafibromin; PRAS40

Indexed keywords

CYTOPLASMIC POLYADENYLATION ELEMENT BINDING PROTEIN; DNA HOMOLOG; ORB PROTEIN; ORB2 PROTEIN; PARAFIBROMIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ALLELE; APOPTOSIS; ARTICLE; BIOINFORMATICS; CDC73 GENE; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; DNA POLYMORPHISM; DROSOPHILA; GENE; GENE FUNCTION; GENE INTERACTION; GENE SILENCING; GENE TARGETING; GENETIC TRANSCRIPTION; HETEROZYGOTE DETECTION; HRPT2 GENE; LIFESPAN; LOSS OF FUNCTION MUTATION; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; RNA TRANSLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ANIMALS; CARBOXY-LYASES; CELL LINE; CHROMATIN IMMUNOPRECIPITATION; DROSOPHILA; DROSOPHILA PROTEINS; HUMANS; LARVA; MRNA CLEAVAGE AND POLYADENYLATION FACTORS; MUTATION; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS; WNT PROTEINS;

MAMMALIA; PROCAVIIDAE;

EID: 77956671163     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2010.32     Document Type: Article

References (34)

1. Jackson CE, Norum RA, Boyd SB, Talpos GB, Wilson SD, Taggart RT et al. Hereditary hyperparathyroidism and multiple ossifying jaw fibromas: a clinically and genetically distinct syndrome. Surgery 1990; 108: 1006-1012.
2. Mallette LE, Malini S, Rappaport MP, Kirkland JL. Familial cystic parathyroid adenomatosis. Ann Intern Med 1987; 107: 54-60.
3. Teh BT, Farnebo F, Kristoffersson U, Sundelin B, Cardinal J, Axelson R et al. Autosomal dominant primary hyperparathyroidism and jaw tumor syndrome associated with renal hamartomas and cystic kidney disease: linkage to 1q21-q32 and loss of the wild type allele in renal hamartomas. J Clin Endocrinol Metab 1996; 81: 4204-4211.
4. Teh BT, Farnebo F, Twigg S, Höög A, Kytöl S, Korpi-Hyövälti E et al. Familial isolated hyperparathyroidism maps to the hyperparathyroidism-jaw tumor locus in 1q21-q32 in a subset of families. J Clin Endocrinol Metab 1998; 83: 2114-2120.
5. Simonds WF, James-Newton LA, Agarwal SK, Yang B, Skarulis MC, Hendy GN et al. Familial isolated hyperparathyroidism: clinical and genetic characteristics of thirty-six kindreds. Medicine (Baltimore) 2002; 81: 1-26.
6. Simonds WF, Robbins CM, Agarwal SK, Hendy GN, Carpten JD, Marx SJ. Familial isolated hyperparathyroidism is rarely caused by germline mutation in HRPT2, the gene for the hyperparathyroidism-jaw tumor syndrome. J Clin Endocrinol Metab 2004; 89: 96-102.
7. Carpten JD, Robbins CM, Villablanca A, Forsberg L, Presciuttini S, Bailey-Wilson J et al. HRPT2, encoding parafibromin, is mutated in hyperparathyroidism-jaw tumor syndrome. Nat Genet 2002; 32: 676-680.
8. Shattuck TM, Valimaki S, Obara T, Gaz RD, Clark OH, Shoback D et al. Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 2003; 349: 1722-1729.
9. Cetani F, Pardi E, Borsari S, Viacava P, Dipollina G, Cianferotti L et al. Genetic analyses of the HRPT2 gene in primary hyperparathyroidism: germline and somatic mutations in familial and sporadic parathyroid tumors. J Clin Endocrinol Metab 2004; 89: 5583-5591.
10. Rozenblatt-Rosen O, Hughes CM, Nannepaga SJ, Shanmugam KS, Copeland TD, Guszczynski T et al. The parafibromin tumor suppressor protein is part of a human Paf1 complex. Mol Cell Biol 2005; 25: 612-620.
11. Yart A, Gstaiger M, Wirbelauer C, Pecnik M, Anastasiou D, Hess D et al. The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II. Mol Cell Biol 2005; 25: 5052-5060.
12. Zhu B, Mandal SS, Pham AD, Zheng Y, Erdjument-Bromage H, Batra SK et al. The human PAF complex coordinates transcription with events downstream of RNA synthesis. Genes Dev 2005; 19: 1668-1673.
13. Mosimann C, Hausmann G, Basler K. Parafibromin/Hyrax activates Wnt/Wg target gene transcription by direct association with beta-catenin/Armadillo. Cell 2006; 125: 327-341.
14. Lin L, Czapiga M, Nini L, Zhang JH, Simonds WF. Nuclear localization of the parafibromin tumor suppressor protein implicated in the hyperparathyroidism- jaw tumor syndrome enhances its proapoptotic function. Mol Cancer Res 2007; 5: 183-193.
15. Woodard GE, Lin L, Zhang JH, Agarwal SK, Marx SJ, Simonds WF. Parafibromin, product of the hyperparathyroidism-jaw tumor syndrome gene HRPT2, regulates cyclin D1/PRAD1 expression. Oncogene 2005; 24: 1272-1276.
16. Zhang C, Kong D, Tan MH, Pappas Jr DL, Wang PF, Chen J et al. Parafibromin inhibits cancer cell growth and causes G1 phase arrest. Biochem Biophys Res Commun 2006; 350: 17-24.
17. Lin L, Zhang JH, Panicker LM, Simonds WF. The parafibromin tumor suppressor protein inhibits cell proliferation by repression of the c-myc proto-oncogene. Proc Natl Acad Sci USA 2008; 105: 17420-17425.
18. 0 mRNA processing factors. Proc Natl Acad Sci USA 2009; 106: 755-760.
19. Greenspan RJ. Chapter 4. Synthesizing specific genotypes. Fly Pushing: The Theory and Practice of Drosophila Genetics. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, 1997. pp 63-86.
20. Singh A, Shi X, Choi KW. Lobe and Serrate are required for cell survival during early eye development in Drosophila. Development (Cambridge, UK) 2006; 133: 4771-4781.
21. Chern JJ, Choi KW. Lobe mediates Notch signaling to control domain-specific growth in the Drosophila eye disc. Development (Cambridge, UK) 2002; 129: 4005-4013.
22. Groisman I, Ivshina M, Marin V, Kennedy NJ, Davis RJ, Richter JD. Control of cellular senescence by CPEB. Genes Dev 2006; 20: 2701-2712.
23. Lasko P. Gene regulation at the RNA layer: RNA binding proteins in intercellular signaling networks. Sci STKE 2003; 2003: RE6.
24. Richter JD. CPEB: a life in translation. Trends Biochem Sci 2007; 32: 279-285.
25. Reifegerste R, Moses K. Genetics of epithelial polarity and pattern in the Drosophila retina. BioEssays 1999; 21: 275-285.
26. Campisi J, d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 2007; 8: 729-740.
27. Mueller CL, Jaehning JA. Ctr9, Rtf1, and Leo1 are components of the Paf1/RNA polymerase II complex. Mol Cell Biol 2002; 22: 1971-1980.
28. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005; 120: 513-522.
29. Campisi J. Aging, tumor suppression and cancer: high wire-act!. Mech Ageing Dev 2005; 126: 51-58.
30. Mendez R, Richter JD. Translational control by CPEB: a means to the end. Nat Rev Mol Cell Biol 2001; 2: 521-529.
31. Burns DM, Richter JD. CPEB regulation of human cellular senescence, energy metabolism, and p53 mRNA translation. Genes Dev 2008; 22: 3449-3460.
32. Nordick K, Hoffman MG, Betz JL, Jaehning JA. Direct interactions between the Paf1 complex and a cleavage and polyadenylation factor are revealed by dissociation of Paf1 from RNA polymerase II. Eukaryot Cell 2008; 7: 1158-1167.
33. Barnard DC, Ryan K, Manley JL, Richter JD. Symplekin and xGLD-2 are required for CPEB-mediated cytoplasmic polyadenylation. Cell 2004; 119: 641-651.
34. Dunlop EA, Tee AR. Mammalian target of rapamycin complex 1: signalling inputs, substrates and feedback mechanisms. Cell Signal 2009; 21: 827-835.